Elusys Therapeutics, INC

A therapeutics company that manufactures novel antitoxins for health security needs.

Based in NJ

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $100K in lobbying spend across 6 quarterly filings, Elusys Therapeutics, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2024 to 2025.

$100K
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2024$20K
2025$80K

Issues Lobbied

MED

Lobbying Firms

The Conafay Group, LLC

Lobbyists

Darin GardnerJosh NarrowBryan Shuy

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED

  • •Advocacy for medical countermeasure funding and support
  • •Advocacy for medical countermeasure funding and support.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Kessler Foundation
$980K total spend
Mt Pharma America, INC.
$800K total spend
National Association of Pediatric Nurse Practitioners
$766K total spend
Glaxosmithkline Consumer Healthcare Holdings (US) LLC DBA Haleon
$620K total spend
Wcg Clinical, INC.
$540K total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.